Protein tyrosine phosphatase receptor type γ (PTPRG) is a tumor suppressor gene, down-regulated in Chronic Myeloid Leukemia (CML) cells by the hypermethylation of its promoter region. β-catenin (CTNNB1) is a critical regulator of Leukemic Stem Cells (LSC) maintenance and CML proliferation. This study aims to demonstrate the antagonistic regulation between β-catenin and PTPRG in CML cells. The specific inhibition of PTPRG increases the activation state of BCR-ABL1 and modulates the expression of the BCR-ABL1- downstream gene β-Catenin. PTPRG was found to be capable of dephosphorylating β-catenin, eventually causing its cytosolic destabilization and degradation in cells expressing PTPRG. Furthermore, we demonstrated that the increased express...
SummaryA key characteristic of hematopoietic stem cells (HSCs) is the ability to self-renew. Genetic...
This study concerns the analysis of the modulation of Chronic Myeloid Leukemia (CML) cell model K562...
A small population of cancer stem cells named the ‘‘side population’ ’ (SP) has been demonstrated to...
Introduction. Chronic Myeloid Leukemia (CML) is a myeloproliferative disease characterized by the pr...
La Leucemia Mieloide Cronica (CML) è una malattia mieloproliferativa caratterizzata dalla presenza d...
Chronic myelogenous leukemia (CML) is the most common myeloproliferative disease. Protein tyrosine p...
none16noChronic myelogenous leukemia (CML) is the most common myeloproliferative disease. Protein ty...
Several studies showed that aberrant DNA methylation is involved in leukemia and cancer pathogenesis...
BACKGROUND: Protein tyrosine phosphatase receptor gamma (PTPRG) is a ubiquitously expressed member ...
Background. Chronic Myelogenous Leukemia (CML) is the most common myeloproliferative disease while ...
Background: Chronic Myelocytic Leukemia (CML) is a clonal myeloproliferative disorder characterized ...
: Tyrosine kinase inhibitors (TKIs) have remarkably transformed Ph+ chronic myeloid leukemia (CML) m...
Canonical Wnt signaling regulates the transcription of T-cell factor (TCF)-responsive genes through ...
The down-modulation of the β-catenin antagonist Chibby 1 (CBY1) associated with the BCR-ABL1 fusion ...
Self-renewal of Bcr-Abl+ chronic myeloid leukemia (CML) cells is sustained by a nuclear activated se...
SummaryA key characteristic of hematopoietic stem cells (HSCs) is the ability to self-renew. Genetic...
This study concerns the analysis of the modulation of Chronic Myeloid Leukemia (CML) cell model K562...
A small population of cancer stem cells named the ‘‘side population’ ’ (SP) has been demonstrated to...
Introduction. Chronic Myeloid Leukemia (CML) is a myeloproliferative disease characterized by the pr...
La Leucemia Mieloide Cronica (CML) è una malattia mieloproliferativa caratterizzata dalla presenza d...
Chronic myelogenous leukemia (CML) is the most common myeloproliferative disease. Protein tyrosine p...
none16noChronic myelogenous leukemia (CML) is the most common myeloproliferative disease. Protein ty...
Several studies showed that aberrant DNA methylation is involved in leukemia and cancer pathogenesis...
BACKGROUND: Protein tyrosine phosphatase receptor gamma (PTPRG) is a ubiquitously expressed member ...
Background. Chronic Myelogenous Leukemia (CML) is the most common myeloproliferative disease while ...
Background: Chronic Myelocytic Leukemia (CML) is a clonal myeloproliferative disorder characterized ...
: Tyrosine kinase inhibitors (TKIs) have remarkably transformed Ph+ chronic myeloid leukemia (CML) m...
Canonical Wnt signaling regulates the transcription of T-cell factor (TCF)-responsive genes through ...
The down-modulation of the β-catenin antagonist Chibby 1 (CBY1) associated with the BCR-ABL1 fusion ...
Self-renewal of Bcr-Abl+ chronic myeloid leukemia (CML) cells is sustained by a nuclear activated se...
SummaryA key characteristic of hematopoietic stem cells (HSCs) is the ability to self-renew. Genetic...
This study concerns the analysis of the modulation of Chronic Myeloid Leukemia (CML) cell model K562...
A small population of cancer stem cells named the ‘‘side population’ ’ (SP) has been demonstrated to...